Viewing nowCombinationCantavel A Tablets 16/10/40 Milligrams
Candesartan Cilexetil 16mg · Amlodipine Besylate 13.88mg +1 more
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.

MFDS item code 202200400 · Approved 2022.01.24 · Insurance code 643308910
Treatment of hypertension, improvement of hyperlipidemia, and prevention of cardiovascular diseases (such as myocardial infarction and stroke)
This medication is used in patients with essential hypertension whose blood pressure is not adequately controlled with Candesartan Cilexetil and Amlodipine combination. The Atorvastatin component helps reduce the risk of cardiovascular diseases and assists in the treatment of hyperlipidemia. It notably reduces the risks of myocardial infarction, stroke, necessity of vascular interventions, and angina, and is effective in diabetic patients and those at high risk for coronary artery disease. In addition, Atorvastatin is used to lower total cholesterol and LDL cholesterol levels while raising HDL cholesterol levels. Thus, this medication is used for hypertension, reduction of cardiovascular disease risk, and improvement of dyslipidemia.
This drug is administered as 1 tablet once daily with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). This drug is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the candesartan cilexetil/amlodipine combination and atorvastatin. Patients taking candesartan cilexetil/amlodipine combination therapy and atorvastatin may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience. ○ Candesartan cilexetil/amlodipine combination It is recommended that the dose of the individual components (candesartan cilexetil or amlodipine) be adjusted before administering the candesartan cilexetil/amlodipine combination; however, a direct switch to the combination may be considered if blood pressure is not controlled as follows. - 8/5 milligrams: For patients whose blood pressure is not adequately controlled with candesartan cilexetil 8 milligrams or amlodipine 5 milligrams. - 16/5 milligrams: For patients whose blood pressure is not adequately controlled with candesartan cilexetil 16 milligrams or amlodipine 5 milligrams. - 16/10 milligrams: For patients whose blood pressure is not adequately controlled with candesartan cilexetil 16 milligrams, amlodipine 10 milligrams, or candesartan cilexetil/amlodipine 16/5 milligrams. ○ Atorvastatin Patients taking atorvastatin before and during treatment should follow a standard cholesterol-lowering diet. The drug may be taken at any time of day, with or without food. Hyperlipidemia The recommended initial dose is atorvastatin 10 mg once daily; however, patients requiring greater reductions in LDL cholesterol may start at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). Atorvastatin is administered at a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses of atorvastatin should be individualized according to the patient's characteristics, considering treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after treatment initiation and/or dose titration, and the dose adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use when initiating treatment and assessing response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor response to treatment. Patients with homozygous familial hypercholesterolemia Atorvastatin is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when such treatments are unavailable. ○ Patients with renal impairment: Because a starting dose of candesartan cilexetil of 4 milligrams once daily is recommended for patients with renal impairment, it is not advisable to use this drug as initial therapy. ○ Patients with hepatic impairment: Because a starting dose of candesartan cilexetil of 2 milligrams once daily is recommended for patients with mild or moderate hepatic impairment, it is not advisable to use this drug as initial therapy.
This medication can cause serious harm to the fetus and newborn if taken during pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. If any issues arise with muscles or if there is a significant increase in muscle-related lab results, this medication should be discontinued, and caution is advised if there is a risk of severe muscle damage. This medication should not be used in individuals with allergies to specific components, pregnant or nursing women, severe liver disease, severe kidney disease, or individuals with hereditary angioedema. Elderly patients, those with hyperkalemia, liver impairment, hypotension, heart valve disease, kidney impairment, etc., should be carefully monitored while using this medication. During the course of this treatment, side effects such as dizziness, headache, edema, muscle pain, dyspepsia, liver function abnormalities, skin rash, and hypotensive symptoms may occur, and if any symptoms arise, consultation with a physician is recommended. This medication lowers blood pressure, so patients may experience symptoms of hypotension or changes in kidney function. Regular monitoring of blood pressure and blood tests is necessary. This medication can interact with others; notify your healthcare provider or pharmacist of any additional medications being taken. Dizziness or drowsiness may occur when driving or operating machinery, so caution is advised. If symptoms such as muscle pain, weakness, fever, or malaise occur during treatment, notify the healthcare provider immediately, and if liver function abnormalities are detected, therapy should be discontinued and medical attention sought. Dosage adjustments may be necessary for patients with certain liver diseases or decreased kidney function, and routine clinical monitoring is advised.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, at a temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness and prevent degradation.
Blue rectangular film-coated tablet
30 tablets/PTP, 10 tablets/PTP
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationCandesartan Cilexetil 16mg · Amlodipine Besylate 13.88mg +1 more
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationCandesartan Cilexetil 8mg · Amlodipine Besylate 6.94mg +1 more
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationCandesartan Cilexetil 16mg · Amlodipine Besylate 6.94mg +1 more
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationCandesartan Cilexetil 8mg · Amlodipine Besylate 6.94mg +1 more
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationCandesartan Cilexetil 16mg · Amlodipine Besylate 6.94mg +1 more
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.